The BC Cancer Agency's Imaging Unit (formerly Cancer Imaging) exploits the interaction of light at both the micro- and macro-scopic level to detect, delineate, grade and treat early (predominantly pre-invasive) cancers.
Research at the BC Cancer Agency's Genetics Unit (formerly Cancer Genetics and Developmental Biology) focuses on identifying genomic changes, and signaling and metabolic pathways associated with tumour progression
Research at the BC Cancer Agency's Department of Cancer Endocrinology is mainly focused on the prevention, early diagnosis and treatment of prostate cancer. Attention is also given to therapeutics for lymphoblastic leukemias and diagnosis of melanoma.
The BC Cancer Agency's Trev & Joyce Deeley Research Centre (DRC), which opened in 2003, is located on Vancouver Island in Victoria, British Columbia, Canada. The DRC is housed in the BC Cancer Agency's Vancouver Island Centre, and serves as a translational research centre that performs "bench-to-bedside" research for patients on Vancouver Island and throughout the province of BC.
The BC Cancer Agency's Radiation Biology Unit (formerly the Department of Medical Biophysics) focuses on improving radiation and drug treatment of solid tumours; studies into the biology and vasculature of solid tumours; and methods of treating tumours and predicting their response to treatment.
The major effort of the
Cancer Control Research (CCR) Program is directed toward reducing cancer incidence and mortality in BC through innovative research projects. The program also plays a key role in the BC Cancer Agency's cancer control activities by monitoring the impact of cancer by region of the province, and by assessing the referral trends for the Agency's cancer clinics. CCR staff are also involved in the scientific direction of the BC Cancer Registry.